Article
Aberrant expression of microRNA-99a and its target gene mTOR associated with malignant progression and poor prognosis in patients with osteosarcoma
1 Mar 2016
Abstract excerpt
BACKGROUND: The mammalian target of rapamycin (mTOR) has been reported to act as a target gene of microRNA (miR)-99a in various cancer cells and identified as an independent prognostic marker of human osteosarcoma. The aim of this study was to investigate the clinical significance of miR-99a/mTOR axis in human osteosarcoma. METHODS: A total of 130 pairs of osteosarcoma and matched noncancerous bone tissues were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
